Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | NPC1 | O15118 | 3/20 | 0.38 |
| ▸ | MAOB | P27338 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22625020 | 0.92 | RAB9A (0.36) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL25848303 | 0.89 | MAOB (0.38) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL25848295 | 0.87 | RAB9A (0.41) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL25848288 | 0.87 | THRB (0.37) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL22625384 | 0.85 | RAB9A (0.38) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL25848272 | 0.85 | RAB9A (0.38) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL22625025 | 0.82 | MAOB (0.37) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL22625082 | 0.81 | RAB9A (0.38) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL25848291 | 0.81 | THRB (0.39) | RAB9ANPC1MAOBALDH1A1HPGD | |
| SCHEMBL25848274 | 0.80 | NPC1 (0.53) | RAB9ANPC1MAOBALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702396-B2 | Hydrophobic compounds for optically active devices | Johnson & Johnson Surgical Vision, Inc. (US) | 2023-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11702396-B2 | Hydrophobic compounds for optically active devices | UACA, CRYZ, TRPA1 | RAB9A 1916/4885NPC1 1051/4885MAOB 3207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.